Clinical Trial Update: Efficacy and Safety of Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of Baricitinib for moderate to severe rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED